10d
Live Science on MSNNew stem cell therapy could repair 'irreversible' and blinding eye damage, trial findsA new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial.The cornea ...
A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...
11d
News Medical on MSNNovel stem cell therapy repairs irreversible corneal damage in clinical trialResults from a Mass Eye and Ear-led phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 ...
Hosted on MSN1mon
Double-Blind, Placebo-Controlled Clinical Trial BasicsIn the context of a clinical trial, double-blind means that neither the patients nor the researchers know who is getting a placebo and who is getting the treatment. Because patients don't know ...
Stem cells from a healthy eye, when transplanted into a damaged eye, safely restored corneal surfaces in 14 patients who were followed for 18 months.
This review was only based on two moderate-sized trials. Blinding of patients was not performed in both trials, causing some risk of bias in outcome assessment since primary endpoints were wholly ...
Methods: Multicentre, randomised, double-blind, parallel-group clinical trial in 64 outpatients with GAD (DSM-IV criteria). Patients were assigned to mexazolam 1mg three times daily (n = 32 ...
An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries ...
A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results